Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #195557 on Innovation Pharmaceuticals Inc (IPIX)
georgejjl
09/03/17 12:40 AM
#195558 RE: Scottwny #195557
This percentage includes patient data from one site where investigator non-compliance may have occurred. Were that site to have been excluded from overall data analysis, as is done in some clinical studies (refer to the journal article linked to below, published findings from another psoriasis study), 43.7% of patients in the 200mg Prurisol arm would have met the primary endpoint.